Blood Reviews

Papers
(The H4-Index of Blood Reviews is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Bridging the evidence-to-practice gap: Advancing neonatal blood transfusion. A narrative review of recent guidelines151
Thalassaemia in China110
Radiation and leukaemia: Which leukaemias and what doses?108
The impact of ABO blood group on COVID-19 infection risk and mortality: A systematic review and meta-analysis106
Classic Hodgkin lymphoma: Pathobiological features that impact emerging therapies97
Editorial Board86
Practical considerations in clinical application of WHO 5th and ICC classification schemes for acute myeloid leukemia77
Beyond current treatment of Fanconi Anemia: What do advances in cell and gene-based approaches offer?64
Philadelphia chromosome-negative myeloproliferative neoplasms in younger adults: A critical discussion of unmet medical needs, with a focus on pregnancy60
Expanding post-transplant cyclophosphamide to matched unrelated donor transplants and beyond56
Putting function back in dysfunction: Endothelial diseases and current therapies in hematopoietic stem cell transplantation and cellular therapies52
Hematopoietic versus leukemic stem cell quiescence: Challenges and therapeutic opportunities50
Editorial Board49
Host-directed therapies modulating innate immunity against infection in hematologic malignancies47
Maternal and neonatal bleeding complications in relation to peripartum management in hemophilia carriers: A systematic review44
TP53 in AML and MDS: The new (old) kid on the block40
Biologic therapies for hypereosinophilic disorders: From tyrosine kinase inhibitors to monoclonal antibodies. Towards an increasingly customized management?40
When hematologic malignancies meet COVID-19 in the United States: Infections, death and disparities38
Management of transfusion-dependent β-thalassemia (TDT): Expert insights and practical overview from the Middle East36
Cell therapy of chronic lymphocytic leukaemia: Transplants and chimeric antigen receptor (CAR)-T cells36
Artificial intelligence in sickle disease36
Getting blood out of a stone: Identification and management of patients with poor hematopoietic cell mobilization35
Pitfalls in laboratory monitoring of treatment in people with Haemophilia35
Not all LGL leukemias are created equal33
Regulatory T cell niche in the bone marrow, a new player in Haematopoietic stem cell transplantation33
Androgen use in bone marrow failures and myeloid neoplasms: Mechanisms of action and a systematic review of clinical data32
Platelet transfusion refractoriness due to HLA alloimmunization: Evolving paradigms in mechanisms and management31
Clinical burden of hemophilia in older adults: Beyond bleeding risk31
Neuro-toxicities of chemo- and immune-therapies in haematologic malignancies: from mechanism to management31
Editorial Board31
0.045526027679443